Today: 30 June 2026
Browse Category

Singapore Stocks 24 January 2026 - 31 January 2026

ST Engineering stock price ticks higher on record S$18.7b contract wins — what traders watch next

ST Engineering stock price ticks higher on record S$18.7b contract wins — what traders watch next

Singapore, Jan 28, 2026, 15:00 — Regular session Shares of Singapore Technologies Engineering Ltd climbed 0.3% to S$9.47 as of 2:49 p.m. local time, following the announcement of a record year in contract wins. The company secured S$4.7 billion in new contracts during the October-December quarter, pushing full-year wins to S$18.7 billion, it said. The stock closed Tuesday at S$9.44.
28 January 2026
··
Yangzijiang Shipbuilding stock lifts to S$3.33 as STI hits a record — what traders watch next

Yangzijiang Shipbuilding stock lifts to S$3.33 as STI hits a record — what traders watch next

Singapore, Jan 27, 2026, 15:00 SGT — Regular session Shares of Yangzijiang Shipbuilding Ltd rose 0.6% to S$3.33 by mid-afternoon Tuesday, tracking the stronger Singapore market ahead of the U.S. Federal Reserve’s policy announcement. The stock fluctuated between S$3.31 and S$3.40, still within striking distance of its 52-week peak at S$3.75, according to market data. The shipbuilder is set to release its next earnings report on March 4.
27 January 2026
··
OCBC share price hits record high — what investors watch before Singapore market reopens

OCBC share price hits record high — what investors watch before Singapore market reopens

Singapore, Jan 25, 2026, 14:47 SGT — Market closed Shares of Oversea-Chinese Banking Corporation climbed to a record S$21.29 on Friday, up 70 Singapore cents, as big banks helped push the Straits Times Index to new highs. United Overseas Bank wrapped at S$39.50, while DBS closed at S$58.65. The STI peaked at 4,895.15 before settling at 4,891.45. Macquarie Capital upgraded UOB to “outperform” and kept its “outperform” call on OCBC, with a target price of S$21.50. Singapore’s three major banks will start reporting full-year results on Feb 9, with OCBC scheduled for Feb 25.
25 January 2026
··
1 2 3 4 … 8

Stock Market Today

  • Talawar Therapeutics to List Nasdaq as It Raises $285M for Atopic Dermatitis Drug
    June 30, 2026, 8:18 AM EDT. Talawar Therapeutics will go public on Nasdaq as 'TLWR' after pulling in $225 million through a PIPE plus $60 million from SPAC JATT II Acquisition, raising $285 million in total. The New Jersey biotech is developing TALA-125, an IL-13/IL-18 bispecific antibody aimed at atopic dermatitis, and is going up against Sanofi and Regeneron's top-selling Dupixent. Talawar says this new approach could get past limits of current therapies by targeting two immune pathways. The company expects to start Phase IIb trials by early 2027, with data coming in late 2028. AD sales could hit $22.4 billion by 2033, even as the field still sees unmet need.
Go toTop